Mizoribine induces remission of relapsed ANCA-associated renal vasculitis

被引：10
作者：
Nishioka, Y
Horita, Y
Tadokoro, M
Taura, K
Suyama, N
Miyazaki, M
Harada, T
Kohno, S
机构：
[1] Nagasaki Municipal Med Ctr, Dept Internal Med, Nagasaki 8528012, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
[3] Nagasaki Univ, Sch Med, Div Renal Care Unit, Nagasaki 852, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷 / 04期
关键词：
antineutrophil cytoplasmic autoantibody-associated renal vasculitis; mizoribine; relapse; renal dysfunction;
D O I：
10.1093/ndt/gfi295
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：1087 / 1088
页数：2
相关论文
共 50 条
  • [31] Predictors of renal outcome in ANCA-associated glomerulonephritis
    Ljubicic, Bojana
    Azasevac, Tijana
    Popovic, Milica
    Zivkovic, Sinisa
    Bozic, Dusan
    Celic, Dejan
    VOJNOSANITETSKI PREGLED, 2021, 78 (07) : 769 - 774
  • [32] Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis
    McClure, Mark E.
    Wason, James
    Gopaluni, Seerapani
    Tieu, Joanna
    Smith, Rona M.
    Jayne, David R.
    Jones, Rachel B.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (05) : 217 - 223
  • [33] Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis
    Haubitz, M
    Koch, KM
    Brunkhorst, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (08) : 2074 - 2076
  • [34] Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
    Silva de Souza, Alexandre Wagner
    Westra, Johanna
    Bijzet, Johan
    Limburg, Pieter C.
    Stegeman, Coen A.
    Bijl, Marc
    Kallenberg, Cees G. M.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [35] Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
    Chalkia, Aglaia
    Thomas, Konstantinos
    Giannou, Panagiota
    Panagiotopoulos, Alexandros
    Hadziyannis, Emilia
    Kapota, Athanasia
    Gakiopoulou, Harikleia
    Vassilopoulos, Dimitrios
    Petras, Dimitrios
    RENAL FAILURE, 2020, 42 (01) : 845 - 852
  • [36] How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy
    Roccatello, Dario
    Fenoglio, Roberta
    De Simone, Emanuele
    Sciascia, Savino
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [37] Different Types of ANCA Determine Different Clinical Phenotypes and Outcome in ANCA-Associated Vasculitis (AAV)
    Bantis, Kostas
    Stangou, Maria J.
    Kalpakidis, Savvas
    Nikolaidou, Christina
    Lioulios, George
    Mitsoglou, Zoi
    Iatridi, Fotini
    Fylaktou, Asimina
    Papagianni, Aikaterini
    FRONTIERS IN MEDICINE, 2022, 8
  • [38] Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: Systematic review
    Birck, R
    Schmitt, WH
    Kaelsch, IA
    van der Woude, FJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : 15 - 23
  • [39] Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis
    Geetha, Duvuru
    Lee, Scott M.
    Shah, Shivani
    Rahman, Hafizur M.
    JOURNAL OF NEPHROLOGY, 2017, 30 (01) : 147 - 153
  • [40] Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
    Goupil, Remi
    Brachemi, Soumeya
    Nadeau-Fredette, Annie-Claire
    Deziel, Clement
    Troyanov, Yves
    Lavergne, Valery
    Troyanov, Stephan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (03): : 416 - 423
12345